Skip to main content
Show full summary

Lord Hunt of Kings Heath to ask Her Majesty's Government what estimate they have made of the cost saving to the NHS for the treatment of Wet Age-Related Macular Degeneration by the use of Avastin instead of the drug Lucentis.  HL3363 [I]

Question HL3363: tabled on 20 November 2017 and due for answer by 4 December 2017

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government what estimate they have made of the cost saving to the NHS for the treatment of Wet Age-Related Macular Degeneration by the use of Avastin instead of the drug Lucentis.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

To view more detailed information about Lords Registered Interests, visit the Lords Register of Interests page.

Lord Hunt of Kings Heath has declared the following interests relevant to this item of business.

President, Health Care Supply Association (purchasing/supply network across UK, with a range of educational programmes)
Trustee, Royal College of Ophthalmologists (interest ceased 31 December 2021)